Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Bullboard Posts
Comment by Righttothetopon Mar 31, 2020 2:21pm
127 Views
Post# 30865219

RE:RE:RE:RE:no hurry to buy any of these

RE:RE:RE:RE:no hurry to buy any of these
flad101 wrote: They showed profit of 1 million.  That's why she is going down 



Umm....here we are again, applying blue chip fundamentals to a spec stock in a spec space.  The market is manipulating this stock, plain and simple.

Theh financials were strong, with guidance of turbulence (for all) ahead.  Sure, that may cause some fear and maybe a bit of a pull back, but even if they pull in only $100mil next year at 10mil EBIT.....that still warrants the action we're seeing?  Hardly......

LABS is not MSFT, AMZN, etc....yet they are very profitable and successful in a startup sector and really the only company with any semblence of success and focus on their global expansion plans....Why is Valens up 6% today?  Cause they're uplisting to the big board??  Hahaha....ya right....what makes anyone think they're in a different universe to LABS?  They're not....neither are any of the other companies with market caps at multiples higher than LABS, yet down LABS goes.....on $125mil top line and $25mil EBIT....that (2 months ago) would have been enough to drive the price to $4-5.....
Bullboard Posts